Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug;10(8):2241-2249.
doi: 10.21037/tp-20-267.

Impacts of prenatal diagnosis of congenital heart diseases on outcomes

Affiliations
Review

Impacts of prenatal diagnosis of congenital heart diseases on outcomes

Damien Bonnet. Transl Pediatr. 2021 Aug.

Abstract

Prenatal diagnosis of congenital heart diseases (CHD) is increasingly performed in developed countries. Still, the current impacts of prenatal diagnosis on fetal and neonatal outcomes remains unclear or contradictory. We will review here the different consequences of prenatal screening and of fetal echocardiography on different categories of outcomes. Increasing detection may lead to a reduced birth incidence of severe complex CHD through a high rate of termination of pregnancy but this trend is not universal. Conversely, one of the main impacts of prenatal diagnosis is to optimize perinatal care and to improve hard outcomes such as mortality. Indeed, decrease of neonatal mortality is inconsistently observed in transposition of the great arteries and is not shown in other defects. The reduction of perinatal morbidity is a new end-point to scrutinize but how to examine this impact is controversial in the neonatal period. The influence of the reduction of neonatal distress may modify neurodevelopmental outcomes and quality of survival. The risk stratification after a prenatal diagnosis of CHD helps to optimize the timing, mode, and site of management with the aim to improve outcomes. The anticipated care is tailored according to the type of CHD and expected initial physiology. However, the imprecision of prenatal diagnosis even in expert centers hampers this logical outcome. Prediction of the type of repair is theoretically possible but remains challenging in defects such as double outlet right ventricles or pulmonary atresia with ventricular septal defect. The cost of prenatal diagnosis or of its absence is still a matter of debate and policies have to be tailored to regional health systems. Finally, the impact on parents and siblings is a rarely explored outcome. Screening and echography of fetal heart are currently performed in developed countries but it is still too early to talk about fetal cardiology.

Keywords: Prenatal diagnosis; cost-effectiveness; fetus; morbidity; mortality.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The author is completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tp-20-267). The series “Pre-natal Diagnosis in Congenital Heart Defects” was commissioned by the editorial office without any funding or sponsorship. The authors have no other conflicts of interest to declare.

Figures

Figure 1
Figure 1
Different impacts of prenatal diagnosis of congenital heart diseases. Practical consequences follow the perinatal organization path with alternate route for the fetus and the parents before and after birth. These technical impacts are permanently associated with the psychological and social consequences of the prenatal diagnosis of the congenital heart disease as well as with the background problematic of cost-effectiveness depending on the local health care system.

Similar articles

Cited by

References

    1. Cloete E, Bloomfield FH, Sadler L, et al. Antenatal Detection of Treatable Critical Congenital Heart Disease Is Associated with Lower Morbidity and Mortality. J Pediatr 2019;204:66-70. 10.1016/j.jpeds.2018.08.056 - DOI - PubMed
    1. Chakraborty A, Gorla SR, Swaminathan S. Impact of prenatal diagnosis of complex congenital heart disease on neonatal and infant morbidity and mortality. Prenat Diagn 2018;38:958-63. 10.1002/pd.5351 - DOI - PubMed
    1. Han B, Li Y, Tang Y, Qu X, et al. Clinical analysis of prenatal ultrasound diagnosis of fetal cardiovascular malformations in the first and second trimesters of pregnancy: A CARE-compliant article. Medicine (Baltimore) 2019;98:e16822. 10.1097/MD.0000000000016822 - DOI - PMC - PubMed
    1. Dolk H, Loane M, Garne E, European Surveillance of Congenital Anomalies (EUROCAT) Working Group . Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005. Circulation 2011;123:841-9. 10.1161/CIRCULATIONAHA.110.958405 - DOI - PubMed
    1. Khoshnood B, De Vigan C, Vodovar V, et al. Trends in prenatal diagnosis, pregnancy termination, and perinatal mortality of newborns with congenital heart disease in France, 1983–2000: a population-based evaluation. Pediatrics 2005;115:95-101. 10.1542/peds.2004-0516 - DOI - PubMed